Tumour Angiogenesis in Cancer.

This project aims to identify the relationship between glucose uptake in tumours, and measures of angiogenesis, which is the growth of blood vessels in response to tumour growth, and blood flow. The process of angiogenesis provides tumours with the nutrients to allow grow, without it, tumour cells can proliferate and then die, causing areas of necrosis. With blood flow into the tumour, systemic therapies such as chemotherapy, Monoclonal antibodies and tyrosine kinase inhibitors can reach the tumour tissue to reduce and reverse tumour growth.

The project employs a variety of radionuclides and imaging techniques, as well histological analysis of angiogenic markers in numerous tumour types to try to untangle the complex relationship between tumour growth and blood flow, to provide an evidence base for the value of non-invasive PET imaging in the prognosis of cancer.

Physics and Engineering Research.

Find out more about the team and the range of projects we are undertaking in the Academic Physics group. The hugely successful group is made up for UCL Leaders, Post-Docs, PhD students and Master students. Find out more here.

Artificial Intelligence and Machine Learning Research.

Molecular Imaging of Interstitial Lung Disease.

CT of the chest is commonly used assess active inflammation in the lungs and therefore help chest physicians with their diagnosis and monitoring of Interstitial Lung Diseases (ILD). In more recent years, Positron Emission Tomography scans have shown that they can detect scarred tissue or fibrosis in the lungs, which can help with the diagnosis of diseases such as Idiopathic Pulmonary Fibrosis (IPF).

This project’s aim is to recruits participants that have been clinically diagnosed with ILD. CT and PET scans are undertaken to help understand how these diseases affect the lungs and how some treatments might improve the participant’s quality of life.

Cardiac and Vascular Imaging Research

Our Research Collaborations

INM has collaborated with many private and non-profit organisations, these include GSK, GE Healthcare, Siemens Heathineers, Cosmonio, Theragnositics, the IAEA and Blue Earth Diagnostics.

COVID-19 Coronavirus Research.

Public and Patient Involvement and Engagement with Research.

We are proactive in getting involved with patients and the public, we seek out there advice before we start new research; and we love to engage with them regarding what we have discovered. Sharing our research outcomes is essential, you can find out more about what we how we do this here.